Search research articles
Contact Us
Filters
Showing results (51-60 of 175) with videos related to
Page
of 18
Sort By:
Molecules (Basel, Switzerland)
|
September 9, 2022
2-(Nitroaryl)-5-Substituted-1,3,4-Thiadiazole Derivatives with Antiprotozoal Activities: In Vitro and In Vivo Study
Alireza Mousavi, Parham Foroumadi, Zahra Emamgholipour, et al.
Current Opinion in Microbiology
|
November 28, 2018
Come, sweet death: targeting glycosomal protein import for antitrypanosomal drug development
Vishal C Kalel, Pascal Mäser, Michael Sattler, et al.
Plos One
|
August 14, 2015
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Marcel Kaiser, Pascal Mäser, Leela Pavan Tadoori, et al.
Plos Neglected Tropical Diseases
|
October 24, 2025
Induced pluripotent stem cell-derived human macrophages as an infection model for Trypanosoma cruzi
Lore Baert, Monica Cal, Thierry Doll, et al.
Molecular Pharmacology
|
June 4, 2005
Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited
Federico Geiser, Alexandra Lüscher, Harry P de Koning, et al.
The Journal of Biological Chemistry
|
January 3, 2008
Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei
Munender Vodnala, Artur Fijolek, Reza Rofougaran, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 19, 2016
Assessing anti-T. cruzi candidates in vitro for sterile cidality
Monica Cal, Jean-Robert Ioset, Matthia A Fügi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 15, 2015
A heteromeric potassium channel involved in the modulation of the plasma membrane potential is essential for the survival of African trypanosomes
Michael E Steinmann, Amaia González-Salgado, Peter Bütikofer, et al.
Current Opinion in Pharmacology
|
June 2, 2012
Antiparasitic agents: new drugs on the horizon
Pascal Mäser, Sergio Wittlin, Matthias Rottmann, et al.
Scientific Reports
|
April 8, 2017
TbIRK is a signature sequence free potassium channel from Trypanosoma brucei locating to acidocalcisomes
Michael E Steinmann, Remo S Schmidt, Peter Bütikofer, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 175) with videos related to
Sort By:
Page
of 18
Molecules (Basel, Switzerland)
|
September 9, 2022
2-(Nitroaryl)-5-Substituted-1,3,4-Thiadiazole Derivatives with Antiprotozoal Activities: In Vitro and In Vivo Study
Alireza Mousavi, Parham Foroumadi, Zahra Emamgholipour, et al.
Current Opinion in Microbiology
|
November 28, 2018
Come, sweet death: targeting glycosomal protein import for antitrypanosomal drug development
Vishal C Kalel, Pascal Mäser, Michael Sattler, et al.
Plos One
|
August 14, 2015
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Marcel Kaiser, Pascal Mäser, Leela Pavan Tadoori, et al.
Plos Neglected Tropical Diseases
|
October 24, 2025
Induced pluripotent stem cell-derived human macrophages as an infection model for Trypanosoma cruzi
Lore Baert, Monica Cal, Thierry Doll, et al.
Molecular Pharmacology
|
June 4, 2005
Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited
Federico Geiser, Alexandra Lüscher, Harry P de Koning, et al.
The Journal of Biological Chemistry
|
January 3, 2008
Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei
Munender Vodnala, Artur Fijolek, Reza Rofougaran, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 19, 2016
Assessing anti-T. cruzi candidates in vitro for sterile cidality
Monica Cal, Jean-Robert Ioset, Matthia A Fügi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 15, 2015
A heteromeric potassium channel involved in the modulation of the plasma membrane potential is essential for the survival of African trypanosomes
Michael E Steinmann, Amaia González-Salgado, Peter Bütikofer, et al.
Current Opinion in Pharmacology
|
June 2, 2012
Antiparasitic agents: new drugs on the horizon
Pascal Mäser, Sergio Wittlin, Matthias Rottmann, et al.
Scientific Reports
|
April 8, 2017
TbIRK is a signature sequence free potassium channel from Trypanosoma brucei locating to acidocalcisomes
Michael E Steinmann, Remo S Schmidt, Peter Bütikofer, et al.
Page
of 18